Income disparities and accessibility to Semaglutide: implications for diabetes management and policy reform

These findings highlighted the significant barriers to accessing semaglutide for low-income individuals. Such individuals are disproportionately affected by diabetes. The affordability of drugs like semaglutide underlines the need for policy interventions to address income-related disparities in healthcare. Expanding insurance coverage, implementing subsidy programs, and introducing price regulation strategies, such as external reference pricing, are potential solutions to improve access to this essential treatment. This study emphasizes the importance of ensuring equitable access to such essential medications regardless of income level.